William Blair Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,848
| Closed | -$1.38M | – | 450 |
|
|
2025
Q1 | $1.38M | Sell |
19,848
-2,154
| -10% | -$178K | ﹤0.01% | 363 |
|
|
2024
Q4 | $1.89M | Sell |
22,002
-30,933
| -58% | -$3.35M | ﹤0.01% | 364 |
|
|
2024
Q3 | $6.3M | Sell |
52,935
-8
| -0% | -$1.07K | 0.02% | 334 |
|
|
2024
Q2 | $7.56M | Sell |
52,943
-480
| -0.9% | -$63.6K | 0.02% | 337 |
|
|
2024
Q1 | $6.86M | Buy |
53,423
+1,185
| +2% | +$141K | 0.02% | 330 |
|
|
2023
Q4 | $5.4M | Sell |
52,238
-9,557
| -15% | -$945K | 0.02% | 332 |
|
|
2023
Q3 | $5.62M | Sell |
61,795
-113
| -0.2% | -$9.95K | 0.02% | 328 |
|
|
2023
Q2 | $5.01M | Sell |
61,908
-356
| -0.6% | -$29.1K | 0.02% | 338 |
|
|
2023
Q1 | $4.95M | Sell |
62,264
-10,662
| -15% | -$756K | 0.02% | 329 |
|
|
2022
Q4 | $4.93M | Buy |
72,926
+1,514
| +2% | +$88.8K | 0.02% | 331 |
|
|
2022
Q3 | $3.56M | Sell |
71,412
-13,684
| -16% | -$733K | 0.01% | 335 |
|
|
2022
Q2 | $4.74M | Sell |
85,096
-32,778
| -28% | -$1.82M | 0.02% | 333 |
|
|
2022
Q1 | $6.54M | Sell |
117,874
-6,450
| -5% | -$331K | 0.02% | 335 |
|
|
2021
Q4 | $6.96M | Buy |
124,324
+4,198
| +3% | +$227K | 0.02% | 352 |
|
|
2021
Q3 | $5.77M | Sell |
120,126
-1,466
| -1% | -$70.9K | 0.02% | 368 |
|
|
2021
Q2 | $5.09M | Buy |
121,592
+10,554
| +10% | +$409K | 0.02% | 276 |
|
|
2021
Q1 | $3.74M | Sell |
111,038
-3,276
| -3% | -$117K | 0.01% | 346 |
|
|
2020
Q4 | $3.99M | Sell |
114,314
-5,200
| -4% | -$180K | 0.01% | 339 |
|
|
2020
Q3 | $4.15M | Sell |
119,514
-2,180
| -2% | -$72.7K | 0.02% | 323 |
|
|
2020
Q2 | $3.98M | Buy |
121,694
+606
| +0.5% | +$19.3K | 0.02% | 314 |
|
|
2020
Q1 | $3.65M | Sell |
121,088
-17,542
| -13% | -$522K | 0.02% | 309 |
|
|
2019
Q4 | $4.01M | Buy |
138,630
+262
| +0.2% | +$7.25K | 0.02% | 328 |
|
|
2019
Q3 | $3.58M | Buy |
+138,368
| New | +$3.5M | 0.02% | 331 |
|
|
2018
Q2 | – | Sell |
-309,814
| Closed | -$7.63M | – | 495 |
|
|
2018
Q1 | $7.63M | Buy |
309,814
+68,482
| +28% | +$1.8M | 0.03% | 333 |
|
|
2017
Q4 | $6.48M | Buy |
241,332
+536
| +0.2% | +$13.6K | 0.03% | 332 |
|
|
2017
Q3 | $5.8M | Buy |
240,796
+95,556
| +66% | +$2.16M | 0.02% | 341 |
|
|
2017
Q2 | $3.12M | Buy |
+145,240
| New | +$2.93M | 0.01% | 384 |
|
|
2016
Q3 | – | Sell |
-167,598
| Closed | -$4.51M | – | 464 |
|
|
2016
Q2 | $4.51M | Sell |
167,598
-6,230
| -4% | -$171K | 0.02% | 359 |
|
|
2016
Q1 | $4.71M | Sell |
173,828
-1,464
| -0.8% | -$39.2K | 0.02% | 353 |
|
|
2015
Q4 | $5.09M | Buy |
175,292
+78,758
| +82% | +$2.18M | 0.02% | 345 |
|
|
2015
Q3 | $2.62M | Buy |
+96,534
| New | +$2.73M | 0.01% | 860 |
|
Other funds holding NVO
F
William Blair Investment Management's NVO Position: Q2 2025 in Review
William Blair Investment Management sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 19,848 shares — an estimated $1.38M sold.
William Blair Investment Management first reported a position in NVO in Q3 2015 and held it in 31 quarters. The position peaked at $7.63M in Q1 2018. 1,482 funds tracked by Wall St. Rank hold NVO as of Q2 2025.
- William Blair Investment Management reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
- William Blair Investment Management sold 19,848 Novo Nordisk shares in Q2 2025, an estimated $1.38M.
- William Blair Investment Management first reported a position in Novo Nordisk in Q3 2015 and held it in 31 quarters.
- William Blair Investment Management's Novo Nordisk position peaked at $7.63M in Q1 2018.
- 1,482 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.
Based on William Blair Investment Management's 13F filing for Q2 2025, filed 29 Jul 2025.